RN3(5-17P22-36)[Q12I]

General Information


DCTPep ID  DCTPep02002

Peptide Name   RN3(5-17P22-36)[Q12I]

Sequence  RPFTRAQWFAIIHISPRTIAMRAINNYRWR

Sequence Length  30

UniProt ID  P12724 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide Membrane-targeted



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
Hep-G2 Hepatoblastoma IC50=59.64±6.17 µM MTT assay 4 h 1

Hemolytic Activity  Sheep erythrocytes: 50% Hemolysis>100µM

Normal (non-cancerous) Cytotoxicity  MRC-5: IC50>100 µM

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep02002

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C172H265N55O38S1

Absent amino acids  CDEGKLV

Theoretical pI  12.30

Acidic residues  0

Basic residues  7

Polar residues  6

Molecular weight (Average)  3743.4

Molecular weight (Monoisotopic)  3741.02

Common amino acids  R

Net charge  7

Instability index (II)  64.34

Aliphatic index  78.33

Grand average of hydropathicity (GRAVY)  -0.400

Half Life 
  1 hours (mammalian reticulocytes, in vitro).
  2 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 12490
  Abs 0.1% (=1 g/l) 3.337

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29763807

Title  Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides

Doi 10.1016/j.ejmech.2018.05.012

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_14143

DCTPep is developed by Dr.Zheng's team.